Is NewGenIvf Group Stock a Good Investment?
NewGenIvf Group Investment Advice | NIVFW |
- Examine NewGenIvf Group's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research NewGenIvf Group's leadership team and their track record. Good management can help NewGenIvf Group navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Healthcare space and any emerging trends that could impact NewGenIvf Group's business and its evolving consumer preferences.
- Compare NewGenIvf Group's performance and market position to its competitors. Analyze how NewGenIvf Group is positioned in terms of product offerings, innovation, and market share.
- Check if NewGenIvf Group pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about NewGenIvf Group's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in NewGenIvf Group Limited stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if NewGenIvf Group Limited is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine NewGenIvf Group Stock
Researching NewGenIvf Group's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if NewGenIvf Group is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding NewGenIvf Group's research are outlined below:
| NewGenIvf Group is way too risky over 90 days horizon | |
| NewGenIvf Group has some characteristics of a very speculative penny stock | |
| NewGenIvf Group appears to be risky and price may revert if volatility continues | |
| NewGenIvf Group has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: NIVF stock touches 52-week low at 0.93 amid market challenges - Investing.com |
NewGenIvf Group's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.06 | |
| Return On Capital Employed | 0.07 | 0.07 | |
| Return On Assets | 0.07 | 0.06 | |
| Return On Equity | 0.13 | 0.26 |
Determining NewGenIvf Group's profitability involves analyzing its financial statements and using various financial metrics to determine if NewGenIvf Group is a good buy. For example, gross profit margin measures NewGenIvf Group's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of NewGenIvf Group's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in NewGenIvf Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NewGenIvf Group Limited. Check NewGenIvf Group's Beneish M Score to see the likelihood of NewGenIvf Group's management manipulating its earnings.
Evaluate NewGenIvf Group's management efficiency
Return On Equity is likely to climb to 0.26 in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025. At this time, NewGenIvf Group's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 1.1 M in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025. NewGenIvf Group's management efficiency ratios could be used to measure how well NewGenIvf Group manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | 0.83 | 1.05 | |
| Enterprise Value Multiple | 0.83 | 1.05 |
The strategic decisions made by NewGenIvf Group management significantly impact its financial stability and market performance. Evaluating these factors helps determine whether the stock is a worthwhile investment.
Beta (0.30) |
Basic technical analysis of NewGenIvf Stock
As of the 25th of March, NewGenIvf Group secures the Risk Adjusted Performance of 0.1113, downside deviation of 26.82, and Mean Deviation of 18.62. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NewGenIvf Group, as well as the relationship between them. Please verify NewGenIvf Group jensen alpha and semi variance to decide if NewGenIvf Group Limited is priced some-what accurately, providing market reflects its recent price of 0.028 per share. As NewGenIvf Group appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.Understand NewGenIvf Group's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing NewGenIvf Group's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1113 | |||
| Market Risk Adjusted Performance | 0.358 | |||
| Mean Deviation | 18.62 | |||
| Semi Deviation | 21.38 | |||
| Downside Deviation | 26.82 | |||
| Coefficient Of Variation | 887.71 | |||
| Standard Deviation | 25.48 | |||
| Variance | 649.24 | |||
| Information Ratio | 0.1137 | |||
| Jensen Alpha | 3.16 | |||
| Total Risk Alpha | 3.89 | |||
| Sortino Ratio | 0.108 | |||
| Treynor Ratio | 0.348 | |||
| Maximum Drawdown | 131.52 | |||
| Value At Risk | (36.44) | |||
| Potential Upside | 45.0 | |||
| Downside Variance | 719.54 | |||
| Semi Variance | 457.04 | |||
| Expected Short fall | (21.32) | |||
| Skewness | 0.3352 | |||
| Kurtosis | 1.4 |
| Risk Adjusted Performance | 0.1113 | |||
| Market Risk Adjusted Performance | 0.358 | |||
| Mean Deviation | 18.62 | |||
| Semi Deviation | 21.38 | |||
| Downside Deviation | 26.82 | |||
| Coefficient Of Variation | 887.71 | |||
| Standard Deviation | 25.48 | |||
| Variance | 649.24 | |||
| Information Ratio | 0.1137 | |||
| Jensen Alpha | 3.16 | |||
| Total Risk Alpha | 3.89 | |||
| Sortino Ratio | 0.108 | |||
| Treynor Ratio | 0.348 | |||
| Maximum Drawdown | 131.52 | |||
| Value At Risk | (36.44) | |||
| Potential Upside | 45.0 | |||
| Downside Variance | 719.54 | |||
| Semi Variance | 457.04 | |||
| Expected Short fall | (21.32) | |||
| Skewness | 0.3352 | |||
| Kurtosis | 1.4 |
Consider NewGenIvf Group's intraday indicators
NewGenIvf Group intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NewGenIvf Group stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NewGenIvf Group time-series forecasting models is one of many NewGenIvf Group's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NewGenIvf Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
NewGenIvf Stock media impact
Far too much social signal, news, headlines, and media speculation about NewGenIvf Group that are available to investors today. That information is available publicly through NewGenIvf media outlets and privately through word of mouth or via NewGenIvf internal channels. However, regardless of the origin, that massive amount of NewGenIvf data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NewGenIvf Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NewGenIvf Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NewGenIvf Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NewGenIvf Group alpha.
NewGenIvf Group Corporate Executives
Elected by the shareholders, the NewGenIvf Group's board of directors comprises two types of representatives: NewGenIvf Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NewGenIvf. The board's role is to monitor NewGenIvf Group's management team and ensure that shareholders' interests are well served. NewGenIvf Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NewGenIvf Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Additional Tools for NewGenIvf Stock Analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.